Elutia

Elutia is pioneering the future of patient care. Their proprietary drug-eluting biomaterial platforms stand at the forefront of medical innovation. They are dedicated to addressing the pressing challenges that can arise from medical device implant failures. By combatting post-surgical complications that impact patient outcomes and escalate medical costs, they’re ensuring patients not only…More recover, but thrive without compromise. Elutia offers a proprietary drug-eluting biologic technology: a fusion of natural biologic material and extended antibiotic release, perfected for device implantation and soft tissue reconstruction. Their offerings, CanGaroo for implantable electronic devices and SimpliDerm for soft-tissue reconstruction, provide robust, but easy-to-use constructs that ensure implant stability and promote wound healing. Notably, both products mitigate fibrotic responses that can lead to poor outcomes.1